Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.67 - $3.19 $339,042 - $1.61 Million
-506,034 Reduced 56.47%
390,066 $441,000
Q1 2022

May 16, 2022

BUY
$2.22 - $3.45 $37,962 - $58,995
17,100 Added 1.95%
896,100 $2.68 Million
Q4 2021

Feb 14, 2022

BUY
$2.36 - $3.57 $165,200 - $249,900
70,000 Added 8.65%
879,000 $2.33 Million
Q3 2021

Nov 15, 2021

BUY
$3.5 - $4.5 $1.98 Million - $2.54 Million
565,000 Added 231.56%
809,000 $2.94 Million
Q2 2021

Aug 16, 2021

SELL
$3.09 - $4.54 $97,335 - $143,010
-31,500 Reduced 11.43%
244,000 $1.06 Million
Q1 2021

May 17, 2021

BUY
$3.35 - $4.93 $922,925 - $1.36 Million
275,500 New
275,500 $942,000
Q3 2020

Nov 16, 2020

SELL
$1.78 - $4.13 $280,706 - $651,301
-157,700 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.63 - $2.62 $32,762 - $52,662
20,100 Added 14.61%
157,700 $295,000
Q2 2018

Aug 13, 2018

SELL
$2.83 - $4.11 $2.16 Million - $3.14 Million
-764,333 Reduced 84.74%
137,600 $389,000
Q1 2018

May 15, 2018

SELL
$3.54 - $4.54 $288,669 - $370,214
-81,545 Reduced 8.29%
901,933 $3.19 Million
Q4 2017

Feb 14, 2018

BUY
$3.23 - $4.3 $1.74 Million - $2.32 Million
540,000 Added 121.76%
983,478 $3.82 Million
Q3 2017

Nov 14, 2017

BUY
$2.18 - $2.57 $966,782 - $1.14 Million
443,478
443,478 $1.13 Million

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.